What Counts as a Strong EHR Pilot ROI?

A convincing EHR pilot ROI case should combine three kinds of evidence: time saved by clinicians, measurable changes in care operations, and financial value that can be verified against the pilot’s full cost. For care-coordination and patient-pulse use cases, the central question is not simply whether software was purchased; it is whether teams spent less time collecting and updating information, followed patients more reliably, and prevented avoidable work without creating new review burden. As of September 26, 2026, many published evaluations of ambient AI emphasize reduced documentation burden and burnout, while some find limited or uncertain financial return. The same caution applies to EHR pilots generally: a favorable user experience is useful evidence, but it is not the same as realized ROI.

Also worth reading: How Can AI Healthcare Compliance Metrics Transform Care Coordination for Clinics and Networks? · How Can Clinics Measure Patient Coordination ROI Beyond Automated Tasks? · How Should Clinics Build a Referral Metrics Dashboard?

A useful pilot should establish a baseline before implementation and use a fixed measurement window afterward. For an eight- to twelve-week pilot, the clinic can compare the prior eight to twelve weeks with the pilot period and, when possible, with similar clinics that were not yet using the tool. The calculation should include subscription fees, implementation time, interface work, training, device expenses, security review, and staff time devoted to administration. At least three thresholds deserve attention: a positive total benefit-cost ratio, a payback period within 12 to 18 months, and improvement in a clinical or operational metric large enough to matter to leadership. If those thresholds are not met, the pilot can still reveal value, but it should not be presented as a proven financial success.

Recommended EHR Pilot ROI Metrics

The strongest measurement framework balances capacity, workflow, patient access, financial performance, and adoption. Each metric needs an owner, a data source, a baseline, and a target; otherwise teams can report percentages without knowing what caused them. It is also important to separate gross time savings from net time savings. If a clinician saves seven minutes per encounter but spends four minutes reviewing a patient-pulse summary before every visit, the net gain is three minutes, not seven.

MetricHow to calculate itPractical target for a pilotMain caveat
Net clinical time savedMinutes avoided minus minutes spent reviewing or correcting system output2–5 minutes per applicable encounter after review timeAvoid double-counting overlapping tasks
Inbox and follow-up capacityCompleted care tasks per clinician day versus baseline5–10% improvement in a controlled pilotMore messages can reflect a backlog being cleared
Documentation timeActive minutes creating notes and prior-authorization support10–20% reduction, depending on baselinePassive EHR idle time is not labor savings
Patient outreach completionReached patients divided by patients eligible for outreach10–20% relative improvementExclude patients already contacted elsewhere
Avoided duplicationDuplicate tests, referrals, or manual data entries per 100 encounters2–5% reductionAttribution may be difficult
Realized financial returnVerified cash savings and margin improvement minus total costBenefit-cost ratio above 1.0; target above 1.5Do not count theoretical capacity as cash
AdoptionEligible users completing the workflow weeklyMore than 70% by pilot midpoint; more than 80% near the endLogins alone do not prove useful use
Safety and qualityMissed high-risk alerts, preventable escalations, or avoidable denialsNo deterioration; targeted improvement where baseline permitsLower event counts can be noise
These targets are operating goals rather than industry-wide guarantees. Clinics should revise them after measuring the current state, because a mature panel with little manual follow-up may have less room for improvement than a clinic with substantial telephone and chart-review work.

Establishing a Credible Financial Baseline

A pilot begins with a cost ledger and a baseline period, not with a favorable testimonial. Capture at least eight weeks of pre-pilot data when feasible, and use the same weekdays and encounter types during the evaluation period. March 2023 is an instructive date for another kind of implementation lesson: reporting at that point that only 5 of 150 participating VA medical centers, about 3%, had piloted a replacement system showed that a large announced program does not guarantee broad operational adoption. Similarly, a health system can announce an EHR or AI pilot before users have changed their daily workflows or demonstrated return.

The cost side should include all implementation categories rather than only the vendor fee. A reasonable example is $15,000 for an 8-week pilot, composed of $10,000 in subscription and usage fees, $3,000 for interface or security work, and $2,000 for training and evaluation support. These figures are illustrative, not quoted market prices, because EHR implementation costs vary sharply by host system, number of clinics, data interfaces, contract terms, and validation requirements. Over a full year, a 20-clinician program that costs $60,000 in software and $30,000 in implementation and internal labor has a $90,000 cost of ownership before benefits are counted.

On the benefit side, distinguish cashable value from capacity value. Cashable value includes fewer denied claims, reduced overtime, avoided temporary staffing, lower interface fees, or measurable reductions in purchased services. Capacity value includes clinician minutes returned to direct care, but it becomes financial only if the organization can convert that time into encounters, faster access, lower burnout, or reduced hiring. Large systems that have discussed return from ambient AI have not eliminated the need for rigorous local measurement; published early evaluations specifically suggest that lower burnout may coexist with limited financial ROI.

Measuring Time, Workload, and Access

Time is often the easiest metric to collect and the easiest to overstate. Measure active minutes spent on notes, inbox work, prior authorization, referrals, and patient outreach; do not count minutes merely because the EHR was open. Manual observation can validate system data because automated timestamps may include waiting, idle time, or several tasks occurring in parallel. A small sample of 20 clinicians observed for two baseline days and two post-pilot days can reveal whether apparent EHR time savings translate into attention for patients.

Capacity should be measured as completed work, not merely initiated work. If the patient-pulse platform helps identify high-risk patients but outreach rises by 30% while completed outreach rises by only 8%, the pilot may have generated activity without closure. Include time to contact, completion rate, escalation rate, duplicate contacts per patient, and time from referral to resolution. Similar logic applies to care coordination: a dashboard showing 500 open tasks is not an ROI result unless compared with the prior open-task queue and accompanied by a plan to resolve it.

Patient access can be represented by third-next-available appointment, time from referral receipt to first contact, and the share of urgent cases reviewed within the organization’s target window. The target should reflect clinical policy rather than a generic SaaS benchmark. For example, a clinic might aim to review flagged deterioration signals within one business day, or contact 80% of patients within two business days. If a tool accelerates identification but the receiving team cannot act because coverage is already saturated, the constraint is capacity rather than software, and the pilot may be premature.

Evaluating Clinical and Financial Alternatives

An EHR workflow feature may be the cheapest option, but it may also require substantial manual work. A dedicated patient-pulse or care-coordination product can be easier to deploy and may offer stronger triage, outreach, and reporting, yet it creates subscription, integration, and data-governance costs. A staffing intervention can produce measurable capacity without a license, while customized analytics can answer narrow operational questions but often require ongoing analyst support. Pilot leaders should compare options against the actual problem instead of assuming that more technology is necessarily superior.

FeatureExisting EHR or manual processDedicated patient-pulse SaaS pilot
Upfront costOften lower if capability already existsSubscription, setup, interface, security, and training costs
ImplementationConfiguration inside a large change processPotentially faster deployment outside core clinical workflows
MeasurementMay require manual extractionMore structured product analytics, depending on vendor
Workflow fitUses one clinical record systemAdds a new interface and notification workflow
ScalabilityManual coordination remains staffing-dependentCan support consistent triage and outreach at higher volume
Main riskHidden staff time and low adoptionDuplicate entry, alert fatigue, or unreviewed output
Best useStable baseline and simple measurementTesting a defined coordination or escalation workflow
Pricing should be evaluated as total cost of ownership per clinician, per active patient, or per care episode. Some vendors charge per provider or per clinic, while others price by messages, seats, integrations, or platform access, so a lower sticker price can be more expensive at larger scale. Request at least three quote scenarios: small pilot, one-year rollout, and multi-clinic expansion. The contract should define what constitutes a billable user, who bears interface changes, how data export and deletion work, and whether support is included. A claim that software is “free” should be tested against implementation labor and the cost of ongoing staff review.

Common Mistakes in EHR Pilot ROI Claims

The most common error is treating a headline benefit as net return. If a pilot saves 40 hours of documentation but adds 20 hours of review, implementation, and troubleshooting, the net result is 20 hours. Another error is valuing every returned minute at a full clinical rate even when the organization has no corresponding demand for additional visits. Capacity has economic value only when leadership has a credible mechanism to redeploy it, such as reducing overtime, absorbing a hiring plan, increasing panel capacity, or improving time to access.

A second mistake is using adoption as a proxy for benefit. Weekly active use above 80% can indicate engagement, but it can also mean employees feel obligated to open the tool. Survey users about whether the workflow saves time, and compare that response with observed or system-derived time. A third mistake is omitting “do no harm” measures. More alerts can increase alarm fatigue, and faster outreach without appropriate review can create unnecessary clinical or legal risk.

Finally, small pilots need uncertainty estimates. If a 10-clinician group shows a 12% improvement in inbox completion, do not assume that all clinics will achieve the same result. Segment results by specialty, baseline workload, user experience, and data completeness. The evaluation should also state what was not measured, such as long-term retention, quality outcomes, or effects after onboarding support ends.

When to Expand, Revise, or Stop a Pilot

Expansion should occur only after the pilot meets predefined decision gates. As a practical rule, proceed when the tool demonstrates more than 70% sustained weekly adoption, at least 5% improvement in a workflow metric tied to the original problem, no material safety deterioration, and a credible financial path to a benefit-cost ratio above 1.0 within 12 to 18 months. Stronger expectations—80% adoption, 10% capacity improvement, and a ratio above 1.5—may be appropriate for a larger rollout, but they should not be represented as universal clinical benchmarks.

A useful next step is a limited expansion rather than an enterprise-wide launch. Extend the pilot from 8 weeks to six months, add one or two comparable clinics, and maintain a matched comparison group if possible. This phase should test whether benefits survive changes in staffing, patient mix, and seasonal demand. Continue if net time remains positive and users can explain why the workflow is valuable. Revise the workflow if adoption is high but net value is weak, since the issue may be review burden or poor integration. Stop or defer if the tool duplicates existing functionality, produces unmanageable false positives, lacks reliable attribution, or cannot be integrated within the organization’s security and clinical-governance requirements.

The timing of the decision matters because indefinite pilots can become expensive habits. Set a decision date before launch, not after results look positive. A clinic that has not achieved measurable value by the end of 12 weeks may need a different configuration, a narrower use case, or no deployment. That is not a failure of the broader care model; it is a result of disciplined experimentation.

A Defensible Pilot Scorecard

A board-ready scorecard should allow an independent reader to reconstruct the economic case. It can present the baseline, target, result, data source, owner, and confidence level for each metric, followed by a financial reconciliation. The final conclusion should separate measured ROI, modeled capacity, and unmeasured potential. For example: verified annual cash benefit of $80,000; estimated capacity value of $45,000; total first-year cost of $75,000; and measured pre-tax net benefit of $5,000 plus $45,000 in capacity that has not yet been converted to cash.

The scorecard should also document negative findings. If patient-pulse outreach improved by 14% but message review added three minutes per case, the net operational result may be small even if the clinical team likes the interface. If a large health system reports strong operational impact from an AI-enabled workflow, that does not prove the same return in a smaller clinic with different staffing, patient volume, or existing infrastructure. External reports, including coverage of Memorial Sloan Kettering’s EHR-to-EDC technology scaling and evaluations of AI scribes, are best treated as context and hypotheses rather than direct evidence for a local business case.

The definitive answer is therefore conservative: an EHR pilot earns the right to scale when it produces verified net benefit, measurable clinical or access improvement, acceptable user burden, and a realistic plan to convert capacity into organizational value. As of September 26, 2026, the best available evidence supports experimentation with health-care AI and workflow technology, but not universal ROI assumptions. The most authoritative clinic will publish its assumptions, show the counter-case, and update the numbers as implementation conditions change.